Anatara Lifesciences Ltd (ASX:ANR)
Australia · Delayed Price · Currency is AUD 0.0110
0.00 (0.00%)
Mar 3, 2026, 2:03 PM AEST
Anatara Lifesciences Market Cap
Anatara Lifesciences has a market cap or net worth of 3.48 million as of March 4, 2026. Its market cap has decreased by -63.97% in one year.
Market Cap
3.48M
Enterprise Value
2.39M
Revenue
623.76K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 16, 2014, Anatara Lifesciences's market cap has decreased from 9.98M to 3.48M, a decrease of -65.16%. That is a compound annual growth rate of -8.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 3.48M | -20.84% |
| Dec 31, 2025 | 4.39M | -56.22% |
| Dec 27, 2024 | 10.03M | 171.52% |
| Dec 22, 2023 | 3.69M | -2.18% |
| Dec 30, 2022 | 3.78M | -62.20% |
| Dec 31, 2021 | 9.99M | -16.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Gene Technology | 10.68M |
| AdAlta | 10.20M |
| Invex Therapeutics | 9.39M |
| Tissue Repair | 9.37M |
| Immuron | 9.15M |
| Chimeric Therapeutics | 8.84M |
| Biotron | 8.11M |
| Nexalis Therapeutics | 7.09M |